Succinate/NLRP3 inflammasome induces synovial fibroblast activation: therapeutical effects of clematichinenoside AR on arthritis
Yi Li, Jia-Yi Zheng, Jian-Qun Liu and 7 more
Frontiers in Immunology · 2016
doi:10.3389/fimmu.2016.00532 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Clematichinenoside AR (C-AR) is a triterpene saponin isolated from the root of Clematis manshurica Rupr., which is a herbal medicine used in traditional Chinese medicine for the treatment of arthritis. C-AR exerts anti-inflammatory and immunosuppressive properties, but little is known about its action in the suppression of fibroblast activation. Low oxygen tension and TGF-β1 induction in the synovium contribute to fibrosis in arthrits. This study was designed to investigate the effect of clematichinenoside AR (C-AR) on synovial fibrosis from the aspects of hypoxic TGF-β1 and HIF-1α induction. In the synovium of rheumatoid arthritis rats, hypoxic TGF-β1 induction increased succinate accumulation due to the reversal of SDH activation and induced NLRP3 inflammasome activation in a manner dependent on HIF-1α induction. In response to NLRP3 inflammsome activation, the released IL-1β further increased TGF-β1 induction, suggesting the forward cycle between inflammation and fibrosis in myofibroblast activation. In the synovium of rheumatoid arthritis rats, C-AR inhibited hypoxic TGF-β1 induction and suppressed succinate-associated NLRP3 inflammasome activation by inhibiting SDH activity, and thereby prevented myofibroblast activation by blocking the cross-talk between inflammation and fibrosis. Taken together, these results showed that succinate worked as a metabolic signaling, linking inflammation with fibrosis through NLRP3 inflammasome activation. These findings suggested that synovial succinate accumulation and HIF-1α induction might be therapeutical targets for the prevention of fibrosis in arthritis.
Abstract licence: CC BY
Cited by papers we hold4
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.